FIELD: medicine.
SUBSTANCE: initial (3 to 12 day) assessment of clinical symptoms of disease (fever and exanthema) is combined with measuring blood serum C-reactive protein (CRP), erythrocyte sedimentation rate (ESR) and specific antibodies (AT) and if observing: - fever response for less than 2 days, exanthema duration for less than 1.5 days, the CRP value less than 7.5 mg/l, ESR less than 15 mm/hour; the IFN-γ level less than 75 pg/ml, circulating immune complex 0.115 optical density units and lower, and specific antibody production more than 8.32 log2, a chronic clinical course of yersiniosis is predicted; - fever response for more than 12 days, exanthema duration for more than 3 days, the CRP value more than 15 mg/l, ESR more than 30 mm/hour; the IFN-γ level more than 150 pg/ml, circulating immune complex 0.130 optical density units and higher, specific antibody production less than 7.32 log2, a severe yersiniosis with associating organ lesions is predicted; - fever response for more than 12 days, exanthema duration for more than 9 days, the CRP value more than 5 mg/l, ESR more than 50 mm/hour; the IFN-γ level less than 150 pg/ml, circulating immune complex 0.250 optical density units and higher, and specific antibody production more than 9.32 log2, clinical outcome of yersiniosis in a systemic disease is predicted.
EFFECT: prevention of a chronic and prolonged clinical course of the disease.
3 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF YERSINIOSIS INFECTION TREATMENT FOR CHILDREN | 2007 |
|
RU2371174C2 |
METHOD OF PREDICTING DISEASE COURSE IN CHILDREN IN CASE OF ACUTE RESPIRATORY VIRAL INFECTIONS | 2009 |
|
RU2424768C2 |
METHOD OF EARLY PROGNOSIS OF THE NATURE OF THE COURSE OF ACUTE RESPIRATORY INFECTION IN CHILDREN | 2017 |
|
RU2659384C1 |
METHOD FOR PREDICTING RISK OF DEVELOPMENT OF NEUROLOGICAL COMPLICATIONS IN ADULT PATIENTS WITH ERYTHEMIC FORM OF IXODID TICK BORREOLISIS | 2015 |
|
RU2611354C1 |
METHOD FOR PREDICTING DEVELOPMENT OF LINGERING FORMS OF YERSINIOSIS INFECTION IN CHILDREN | 2001 |
|
RU2193201C1 |
METHOD FOR CARRYING OUT INTERFERON THERAPY | 1995 |
|
RU2105566C1 |
METHOD FOR PREDICTION OF CLINICAL OUTCOME OF PSEUDOTUBERCULOSIS INFECTION IN CHILDREN | 2014 |
|
RU2568904C1 |
METHOD FOR PREDICTING THE FLOW OF INFECTIOUS MONONUCLEOSIS CAUSED WITH EPSTEIN-BARR VIRUS IN CHILDREN | 2005 |
|
RU2285262C1 |
METHOD FOR EVALUATING PROBABILITY OF OUTCOMES OF A NON-ERYTHEMATOUS FORM OF IXODID TICK-BORNE BORRELIOSIS AND A COMBINED COURSE OF BORRELIOSIS-ENCEPHALITIS INFECTION | 2017 |
|
RU2657830C1 |
METHOD FOR DIFFERENTIAL DIAGNOSIS OF LATENT AND ACTIVE FORMS OF HHV-6 INFECTION IN CHILDREN | 2023 |
|
RU2817089C1 |
Authors
Dates
2011-06-27—Published
2010-01-11—Filed